CD44: a multifunctional mediator of cancer progression
CD44, a non-kinase cell surface transmembrane glycoprotein, has been widely implicated
as a cancer stem cell (CSC) marker in several cancers. Cells overexpressing CD44 possess …
as a cancer stem cell (CSC) marker in several cancers. Cells overexpressing CD44 possess …
The biology and role of CD44 in cancer progression: therapeutic implications
C Chen, S Zhao, A Karnad, JW Freeman - Journal of hematology & …, 2018 - Springer
CD44, a non-kinase transmembrane glycoprotein, is overexpressed in several cell types
including cancer stem cells and frequently shows alternative spliced variants that are …
including cancer stem cells and frequently shows alternative spliced variants that are …
A novel MIF signaling pathway drives the malignant character of pancreatic cancer by targeting NR3C2
Pancreatic cancers with aberrant expression of macrophage migration inhibitory factor (MIF)
are particularly aggressive. To identify key signaling pathways that drive disease …
are particularly aggressive. To identify key signaling pathways that drive disease …
CD44 splice isoform switching determines breast cancer stem cell state
H Zhang, RL Brown, Y Wei, P Zhao, S Liu… - Genes & …, 2019 - genesdev.cshlp.org
Although changes in alternative splicing have been observed in cancer, their functional
contributions still remain largely unclear. Here we report that splice isoforms of the cancer …
contributions still remain largely unclear. Here we report that splice isoforms of the cancer …
The role of CD44 in epithelial–mesenchymal transition and cancer development
H Xu, Y Tian, X Yuan, H Wu, Q Liu… - OncoTargets and …, 2015 - Taylor & Francis
CD44, a multi-structural and multifunctional transmembrane glycoprotein, was initially
identified as a receptor for hyaluronan that participates in both physiological and …
identified as a receptor for hyaluronan that participates in both physiological and …
The Hydroxyquinoline Analogue YUM70 Inhibits GRP78 to Induce ER Stress–Mediated Apoptosis in Pancreatic Cancer
Abstract GRP78 (glucose-regulated protein, 78 kDa) is a key regulator of endoplasmic
reticulum (ER) stress signaling. Cancer cells are highly proliferative and have high demand …
reticulum (ER) stress signaling. Cancer cells are highly proliferative and have high demand …
CD44/CD44v6 a reliable companion in cancer-initiating cell maintenance and tumor progression
Z Wang, K Zhao, T Hackert, M Zöller - Frontiers in cell and …, 2018 - frontiersin.org
Metastasis is the leading cause of cancer death, tumor progression proceeding through
emigration from the primary tumor, gaining access to the circulation, leaving the circulation …
emigration from the primary tumor, gaining access to the circulation, leaving the circulation …
POLQ inhibition elicits an immune response in homologous recombination–deficient pancreatic adenocarcinoma via cGAS/STING signaling
G Oh, A Wang, L Wang, J Li, G Werba… - The Journal of …, 2023 - Am Soc Clin Investig
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy that harbors
mutations in homologous recombination–repair (HR-repair) proteins in 20%–25% of cases …
mutations in homologous recombination–repair (HR-repair) proteins in 20%–25% of cases …
TRIM family contribute to tumorigenesis, cancer development, and drug resistance
N Huang, X Sun, P Li, X Liu, X Zhang, Q Chen… - … Hematology & Oncology, 2022 - Springer
The tripartite-motif (TRIM) family represents one of the largest classes of putative single
protein RING-finger E3 ubiquitin ligases. TRIM family is involved in a variety of cellular …
protein RING-finger E3 ubiquitin ligases. TRIM family is involved in a variety of cellular …
KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
Z Zhang, H Zhang, X Liao, H Tsai - Frontiers in Cell and …, 2023 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer. It
has a poor response to conventional therapy and has an extremely poor 5-year survival rate …
has a poor response to conventional therapy and has an extremely poor 5-year survival rate …